In vitro approach to evaluate the potential of botanicals to cause hepatotoxicity and drug interactions: Milk thistle, yohimbe, and kava as case studies
Planta Medica · 01.03.2026 · 92 (03) · 406
DOI: 10.1055/s-0045-1815422 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.03.2026. Verfasst von S Khan und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Herbal medicines and dietary supplements are frequently implicated in liver injury and botanical-drug interactions (BDIs), yet mechanistic understanding is limited. The Botanical Safety Consortium (BSC), a public-private partnership led by FDA, NIEHS, and HESI, is advancing safety assessment strategies for botanicals using in vitro and in silico tools. This study aims to present a case study-based approach to assess hepatotoxicity and BDI potential of three botanicals, Milk thistle ( Silybum marianum ), Yohimbe ( Pausinystalia johimbe ), and Kava ( Piper methysticum ), using an integrated battery of in vitro assays. The selected botanicals were evaluated for cytotoxicity, CYP3A4 inhibition/induction, metabolite formation, and transcriptomics in 2D and 3D human hepatocyte models. Kava exhibited strong CYP3A4 induction and formed reactive metabolites in metabolic activation assays, consistent with its suspected hepatotoxic risk. Yohimbe induced CYP3A4 mRNA without metabolite formation, marking the first report of its potential for BDI. Milk thistle, often considered hepatoprotective, showed glutathione conjugate formation from taxifolin even without metabolic activation—suggesting a redox-based mechanism possibly underlying its Nrf2-mediated antioxidant response. 3D models confirmed sub-cytotoxic CYP3A4 inhibition by Yohimbe and Kava and highlighted differential cytotoxicity across endpoints (LDH leakage, albumin production). In conclusion, this study demonstrates the utility of integrated in vitro methods for botanical safety profiling and highlights the unique mechanistic fingerprints of each extract. Future efforts will focus on physiologically based pharmacokinetic (PBPK) modeling and clinical translation of these findings, especially for Yohimbe and Kava. Publication History Article published online: 05 March 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Khan, S., Roe, A., Mitchell, C., Krzykwa, J., & Ferugson, S. (2026). In vitro approach to evaluate the potential of botanicals to cause hepatotoxicity and drug interactions: Milk thistle, yohimbe, and kava as case studies. Planta Medica, 92(03), 406. https://doi.org/10.1055/s-0045-1815422
Vancouver
Khan S, Roe A, Mitchell C, Krzykwa J, Ferugson S. In vitro approach to evaluate the potential of botanicals to cause hepatotoxicity and drug interactions: Milk thistle, yohimbe, and kava as case studies. Planta Medica. 2026;92(03):406. doi:10.1055/s-0045-1815422
BibTeX
@article{Khan2026,
author = {Khan, S and Roe, A and Mitchell, C and Krzykwa, J and Ferugson, S},
title = {In vitro approach to evaluate the potential of botanicals to cause hepatotoxicity and drug interactions: Milk thistle, yohimbe, and kava as case studies},
journal = {Planta Medica},
year = {2026},
volume = {92},
number = {03},
pages = {406},
doi = {10.1055/s-0045-1815422}
}
EUVIMED